Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - STOCK-BASED COMPENSATION
Stock-based Compensation PRLD - Prelude Therapeutics Incorporated
25.6 M
LAST VALUE
10.63%
2 YEAR CAGR
169.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR